BNTC
Benitec Biopharma·NASDAQ
--
--(--)
--
--(--)
5.12 / 10
Netural
The fundamental evaluation yields a score of 5.1/10, indicating modest financial health. Key positives include a healthy interest coverage ratio and strong revenue growth, while limitations such as high days sales outstanding and suboptimal PB-ROE suggest room for improvement. Overall, the financial profile is mixed, warranting cautious optimism.
Analysis Checks(8/10)
Revenue-MV
Value-0.26
Score3/3
Weight19.90%
1M Return10.54%
Value-0.26
Score3/3
Weight19.90%
1M Return10.54%
Days sales outstanding
Value313.91
Score1/3
Weight-2.19%
1M Return-1.57%
Value313.91
Score1/3
Weight-2.19%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight15.88%
1M Return8.45%
Value-0.17
Score2/3
Weight15.88%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.59%
1M Return-1.11%
Value42.48
Score2/3
Weight-1.59%
1M Return-1.11%
Asset-MV
Value-1.79
Score3/3
Weight29.42%
1M Return13.15%
Value-1.79
Score3/3
Weight29.42%
1M Return13.15%
Total operating revenue (YoY growth rate %)
Value45.97
Score2/3
Weight1.70%
1M Return1.11%
Value45.97
Score2/3
Weight1.70%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight15.87%
1M Return8.45%
Value0.46
Score2/3
Weight15.87%
1M Return8.45%
PB-ROE
Value2.36
Score0/3
Weight4.74%
1M Return2.72%
Value2.36
Score0/3
Weight4.74%
1M Return2.72%
Operating revenue (YoY growth rate %)
Value64.40
Score2/3
Weight0.65%
1M Return0.43%
Value64.40
Score2/3
Weight0.65%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight15.60%
1M Return8.41%
Value-0.07
Score2/3
Weight15.60%
1M Return8.41%
Revenue-MV
Value-0.26
Score3/3
Weight19.90%
1M Return10.54%
Value-0.26
Score3/3
Weight19.90%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value45.97
Score2/3
Weight1.70%
1M Return1.11%
Value45.97
Score2/3
Weight1.70%
1M Return1.11%
Days sales outstanding
Value313.91
Score1/3
Weight-2.19%
1M Return-1.57%
Value313.91
Score1/3
Weight-2.19%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight15.87%
1M Return8.45%
Value0.46
Score2/3
Weight15.87%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight15.88%
1M Return8.45%
Value-0.17
Score2/3
Weight15.88%
1M Return8.45%
PB-ROE
Value2.36
Score0/3
Weight4.74%
1M Return2.72%
Value2.36
Score0/3
Weight4.74%
1M Return2.72%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.59%
1M Return-1.11%
Value42.48
Score2/3
Weight-1.59%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value64.40
Score2/3
Weight0.65%
1M Return0.43%
Value64.40
Score2/3
Weight0.65%
1M Return0.43%
Asset-MV
Value-1.79
Score3/3
Weight29.42%
1M Return13.15%
Value-1.79
Score3/3
Weight29.42%
1M Return13.15%
Cash-MV
Value-0.07
Score2/3
Weight15.60%
1M Return8.41%
Value-0.07
Score2/3
Weight15.60%
1M Return8.41%
Is BNTC undervalued or overvalued?
- BNTC scores 5.12/10 on fundamentals and holds a Fair valuation at present. Backed by its -9.39% ROE, 0.00% net margin, -9.93 P/E ratio, 4.44 P/B ratio, and -166.06% earnings growth, these metrics solidify its Netural investment rating.
